J Korean Liver Cancer Stud Search


J Liver Cancer > Volume 13(2); 2013 > Article
Journal of the Korean Liver Cancer Study 2013;13(2):152-157.
DOI: https://doi.org/10.17998/jlc.13.2.152    Published online September 30, 2013.
A Case of Partial Response of Hepatocellular Carcinoma Induced by Concurrent Chemoradiation and Hepatic Arterial Infusion Chemotherapy after Trans-Arterial Chemoembolization
Myung Eun Song1, Sangheun Lee1, Mi Na Kim1, Dong-Jun Lee1, Beom Kyung Kim1,2, Seung Up Kim1,2,3,5, Jun Yong Park1,2,3,5, Sang Hoon Ahn1,2,3,5, Chae Yoon Chon1,2,3,5, Kwang-Hyub Han1,2,3,5, Jinsil Seong3,4, Do Young Kim1,2,3,5
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2Department of Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea
3Severance Hospital Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea
4Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea
5Yonsei University Health System Liver Cirrhosis Clinical Research Center, Seoul, Korea
Correspondence:  Do Young Kim,
Email: DYK1025@yuhs.ac
Copyright ©2013 by The Korean Liver Cancer Association
A 63-year-old man patient was referred for treatment of infiltrative hepatocellular carcinoma with hilar invasion after transarterial chemoembolization. Serum alkaline phosphatase and bilirubin were elevated, liver dynamic CT showed infiltrative type mass in left hepatic lobe and right hepatic dome with hilar invasion and left intrahepatic duct dilatation. Also CT showed obliteration of left portal vein and metastasis of lymph node around common bile duct. He was diagnosed as hepatocellular carcinoma (UICC stage IV-A, BCLC stage C). With the percutaneous transhepatic biliary drainage and the concurrent chemoradiation therapy and the 4th cycle of hepatic arterial infusion chemotherapy for infiltrative mass, viable tumor was decreased in resectable size at eight months from initial diagnosis.
Key Words: Hepatocellular carcinoma; Concurrent chemoradiation; Hepatic arterial infusion chemotherapy


Browse all articles >

Editorial Office
1527 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2020 by The Korean Liver Cancer Association. All rights reserved.

Developed in M2community

Close layer
prev next